At Treatment Action Group (TAG), we believe in the power of social media to amplify support and spread awareness. By utilizing social media platforms and online communities, you can celebrate your special occasions while expanding your impact and raising awareness…
Treatment Action Group (TAG) is seeking passionate individuals committed to ending the epidemics of HIV, hepatitis C (HCV), and tuberculosis (TB) to join our oard of directors. As a member of TAG's Board, you will play a pivotal role in…
Supporting Treatment Action Group (TAG) through Donor Advised Funds (DAFs) empowers you to maximize the impact of your philanthropy. A Donor Advised Fund is a flexible giving vehicle that allows you to make a charitable contribution, receive an immediate tax…
Join our community of dedicated supporters who are making a real difference in the fight against HIV, hepatitis C (HCV), and tuberculosis (TB). By becoming a monthly donor to Treatment Action Group (TAG), you can contribute to our life-saving work…
You have the power to create a lasting impact on the fight against HIV, hepatitis C, and tuberculosis by making a planned gift to Treatment Action Group (TAG). Planned gifts involve incorporating TAG into your long-term financial and estate planning,…
One powerful way to maximize the impact of your donation to TAG is by taking advantage of your company's matching gifts program. Many companies offer this fantastic opportunity, enabling you to amplify your contribution and make an even greater difference…
By making a gift of stock to Treatment Action Group (TAG), you have the opportunity to support our life-saving work while also receiving valuable benefits for yourself. Whether you purchased the stock at a lower price or it has appreciated…
After over a year of sustained advocacy from the TB community demanding that Johnson & Johnson publicly commit to non-enforcement or withdrawal of secondary patents on bedaquiline filed in 66 low- and middle-income countries (LMICs)...
TAG and 82 other organizations and 106 individuals representing TB-affected communities and civil society sent an open letter to Johnson & Johnson calling on the company...
On 15 June, 2023, TB Europe Coalition (TBEC) organized a webinar featuring a presentation by Treatment Action Group’s TB Project Officer, David Branigan, on the practical actions advocates can take to promote the adoption and scale up of shorter, safer 1/4/6 regimens for TB prevention and the treatment of drug-sensitive and drug-resistant TB as well as supportive diagnostics.